Drug Database
DO

donepezil (E 2022 / TK023 / TK 023)

✓ Approved

Eisai Co., Ltd. · ACHE · 小分子

什么是 donepezil?

donepezil 是一种小分子,由Eisai Co., Ltd.研发。该药已获批,用于治疗相关适应症,给药途径:Transdermal。

药物档案

商品名E 2022, TK023, TK 023
公司Eisai Co., Ltd.
药物类别小分子
分子靶点ACHE
给药途径Transdermal
状态Approved

作用机制

分子靶点

donepezil 作用于 1 个分子靶点:

ACHEacetylcholinesterase (Cartwright blood group) (N-ACHE, ACEE)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

donepezil 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Nervous system disordersDementia Alzheimer's typePhase I

相关研究文献

PubMedInternational journal of biological macromolecules2026-07-27

Donepezil nanocrystals-incorporated carboxymethyl cellulose nanopaste for high-payload transdermal delivery with improved skin compatibility.

Yang In Gyu IG, Heo Jae Yoon JY, Myung Jin Hyuk JH, Jeong Min Young MY et al.

Donepezil (DPZ), an acetylcholinesterase inhibitor for Alzheimer's disease, suffers from skin irritation during transdermal delivery. Herein, a drug high-payload nanopaste (NP) system was designed employing carboxymethyl cellulose (CMC) to enhance transdermal delivery of DPZ while mitigating cutaneous irritation. DPZ NPs (10, 20, and 27.5% w/v) were fabricated via wet bead-milling with low-molecular-weight CMC (90 K) to obtain submicron particles, followed by incorporation into high-molecular-weight CMC (700 K) matrix. The drug nanocrystals were uniformly distributed in the CMC matrix, preserving crystal size (505.6-563.8 nm), zeta potential (-48.93 to -51.95 mV), and crystallinity. Fourier-transform infrared analysis revealed the electrostatic interaction between the anionic polymers and drug nanocrystals. Pharmacokinetic evaluations in rats revealed that while the 10% NP achieved systemic absorption comparable to the commercial patch, the 20% NP provided a 2.1-fold higher transdermal absorption. Level A IVIVC analysis established a robust correlation (R2 > 0.96) between in vitro dissolution profile and in vivo absorption. Crucially, the CMC-based NPs showed markedly improved dermal tolerability, showing minimal hyperplasia and inflammation compared to acrylic-based commercial patches. Additionally, NPs were chemically stable under accelerated conditions without antioxidants. These findings suggest that CMC-based NP system of DPZ represents a biocompatible transdermal platform for long-term Alzheimer's therapy.

PMID 42503382
阅读全文 →
PubMedEuropean journal of dermatology : EJD2026-07-27

sQUIZ your knowledge! A long-lasting hypopigmented patch on a young adult.

Fialho Maria Cristina MC, Ferreirinha Ana A, Fernandes Cândida C

PMID 42507416
阅读全文 →
PubMedJournal of neurogastroenterology and motility2026-07-27

Symptomatic Inlet Patch as a Cause of Chronic Cough and Dysphagia: A Case Report.

Aznar Ruiz Elena E, Zataraín Vallés Ana A, Aparicio Cabezudo Marta M, García Pravia Laura L et al.

PMID 42504662
阅读全文 →
PubMedACS applied materials & interfaces2026-07-27

A Flexible PPDO-co-PEG-Based Copolymer Tissue Patch with High Interfacial and Cohesive Strength for Reliable Sealing and Rapid Closure of Wet Tissue.

Yan Lan-Xi LX, Zhang Jie J, Chen Xiao-Hu XH, Cao Yu-Tao YT et al.

Tissue patches have gained widespread attention for their ability to rapidly and effectively close tissue wounds. Nevertheless, maintaining robust adhesive strength under physiological conditions remains a significant challenge for current tissue adhesion materials. Herein, a tissue patch material based on a poly(p-dioxanone)-co-poly(ethylene glycol) (PPDO-co-PEG) copolymer is reported. This copolymer is engineered to exhibit a rigid-to-flexible transition property, with N-hydroxysuccinimide (NHS) groups grafted onto its backbone as adhesive functional moieties. The semi-crystalline structure of the PPDO segments enhances cohesive strength, while PEG segments provide segmental mobility under physiological conditions, enabling NHS to penetrate irregular tissue interfaces and react with surface primary amine groups. Therefore, the patch exhibits excellent tissue adhesion performance, with dry and wet adhesive strength of 2.59 MPa and 189.6 kPa, respectively. Furthermore, the patch has the potential for multifunctional applications, such as effectively sealing wounds in multiple organs with outstanding pressure-resistant stability (326 mmHg), while also offering rapid hemostasis and accelerated tissue healing. In summary, this study presents a feasible design strategy for flexible, high-adhesion tissue patches, which show promising potential for clinical applications in wound management and tissue repair.

PMID 42504473
阅读全文 →
PubMedCells2026-07-27

Membrane Fusion-Based Mirabilis Himalaica-Derived Exosome-like Nanoparticles Fused with Cell-Penetrating Peptide Mediated for Chebulinic Acid Delivery Against UVA-Induced Photoaging.

Zhao Weiwei W, Yang Siqi S, Liu Ruobing R, Liu Chaozhi C et al.

Exposure to ultraviolet (UV), particularly UVA radiation, is a primary driver of photoaging due to its deep dermal penetration, which triggers DNA damage, collagen degradation, and immune suppression. Chebulinic acid (CA), a polyphenolic compound from Terminalia chebula, exhibits potent antioxidant and anti-inflammatory properties against UVB-induced skin damage. However, its large molecular weight hinders transdermal delivery and the TAT47-57 peptide (core of HIV-1 TAT) enables rapid transmembrane transport. Large particles with double-layer membrane structure and a diameter exceeding 1000 nm were obtained during the separation of plant-derived exosome-like nanoparticles (PELNs), which are not considered as PELNs (50-500 nm), after a mixture with TAT anchored to the surface of engineered artificial vesicles (EAVs) and extrusion causes membrane fusion, employed as novel nanocarriers to overcome the difficulty in skin penetration by leveraging their lipid bilayer structure and surface membrane-anchored TAT for efficient epidermal fusion and intercellular penetration. Furthermore, CA-loaded TAT-ePELNs demonstrate significant efficacy in mitigating UVA-induced photoaging. Collectively, this study expands the anti-UVR damage application spectrum of CA from UVB to UVA exposure and establishes a green, efficient, and biosafe strategy for transdermal drug delivery by utilization of non-PELNs generated during the preparation process of PELNs.

PMID 42505345
阅读全文 →
PubMedACS applied materials & interfaces2026-07-27

Flexible Radioactive Patch: Reshaping the Paradigm for Scar and Cutaneous Tumor Treatment.

Huang Qian Q, Wang Jie J, Wang Dong D, Qin Yu Y et al.

The treatment of skin diseases, including hypertrophic scars and cutaneous melanoma, remains clinically challenging. Conventional radionuclide (e.g., 90Sr, 32P) patches for beta-ray external beam radiotherapy suffer from rigid structures, leading to off-target irradiation, uneven radionuclide distribution, inconsistent dosing, and potential leakage risks. To address these limitations, we developed an innovative, flexible radioactive patch (32P-RU) by integrating 32P-loaded resin microspheres with boric acid-modified flexible polydimethylsiloxane (PBDMS) gel (P4U), enabling robust adsorption of H32PO42-, homogeneous distribution, and precise, repeated reshaping to conform to irregular lesions. As a pure beta emitter, 32P (Emax = 1.71 MeV, T1/2 = 14.28 d, tissue penetration depth = 4 mm) minimizes damage to adjacent normal tissues. In preclinical models, 32P-RU demonstrated significant therapeutic efficacy: in rabbit ear hypertrophic scar models, five 4 Gy fractions reduced scar volume and improved collagen organization; in murine subcutaneous melanoma models, five 8 Gy fractions effectively suppressed tumor growth. Notably, combining 32P-RU with the immune checkpoint inhibitor (anti-PD-L1) synergistically enhanced anti-tumor effect, promoting dendritic cell maturation, increasing CD8+ T cell infiltration, and suppressing both primary and distant tumors. This conformal, safe, and effective 32P-RU patch offers a strategy for the precise treatment of superficial skin diseases, including refractory cutaneous malignancies.

PMID 42504417
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多donepezil